These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23238081)

  • 41. Thyroid function in Rett syndrome.
    Stagi S; Cavalli L; Congiu L; Scusa MF; Ferlini A; Bigoni S; Benincasa A; Rossi B; Pini G
    Horm Res Paediatr; 2015; 83(2):118-25. PubMed ID: 25614013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MeCP2 Rett mutations affect large scale chromatin organization.
    Agarwal N; Becker A; Jost KL; Haase S; Thakur BK; Brero A; Hardt T; Kudo S; Leonhardt H; Cardoso MC
    Hum Mol Genet; 2011 Nov; 20(21):4187-95. PubMed ID: 21831886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene.
    Bartholdi D; Klein A; Weissert M; Koenig N; Baumer A; Boltshauser E; Schinzel A; Berger W; Mátyás G
    Clin Genet; 2006 Apr; 69(4):319-26. PubMed ID: 16630165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
    Tao J; Wu H; Sun YE
    Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
    Peddada S; Yasui DH; LaSalle JM
    Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age-dependent expression of MeCP2 in a heterozygous mosaic mouse model.
    Smrt RD; Pfeiffer RL; Zhao X
    Hum Mol Genet; 2011 May; 20(9):1834-43. PubMed ID: 21330301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RettBASE: Rett syndrome database update.
    Krishnaraj R; Ho G; Christodoulou J
    Hum Mutat; 2017 Aug; 38(8):922-931. PubMed ID: 28544139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Normal histone modifications on the inactive X chromosome in ICF and Rett syndrome cells: implications for methyl-CpG binding proteins.
    Gartler SM; Varadarajan KR; Luo P; Canfield TK; Traynor J; Francke U; Hansen RS
    BMC Biol; 2004 Sep; 2():21. PubMed ID: 15377381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome.
    Kahanovitch U; Patterson KC; Hernandez R; Olsen ML
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome.
    Ehinger Y; Matagne V; Cunin V; Borloz E; Seve M; Bourgoin-Voillard S; Borges-Correia A; Villard L; Roux JC
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations.
    Vecsler M; Ben Zeev B; Nudelman I; Anikster Y; Simon AJ; Amariglio N; Rechavi G; Baasov T; Gak E
    PLoS One; 2011; 6(6):e20733. PubMed ID: 21695138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exclusive expression of MeCP2 in the nervous system distinguishes between brain and peripheral Rett syndrome-like phenotypes.
    Ross PD; Guy J; Selfridge J; Kamal B; Bahey N; Tanner KE; Gillingwater TH; Jones RA; Loughrey CM; McCarroll CS; Bailey ME; Bird A; Cobb S
    Hum Mol Genet; 2016 Oct; 25(20):4389-4404. PubMed ID: 28173151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.
    Mellios N; Feldman DA; Sheridan SD; Ip JPK; Kwok S; Amoah SK; Rosen B; Rodriguez BA; Crawford B; Swaminathan R; Chou S; Li Y; Ziats M; Ernst C; Jaenisch R; Haggarty SJ; Sur M
    Mol Psychiatry; 2018 Apr; 23(4):1051-1065. PubMed ID: 28439102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired mitochondrial quality control in Rett Syndrome.
    Crivellari I; Pecorelli A; Cordone V; Marchi S; Pinton P; Hayek J; Cervellati C; Valacchi G
    Arch Biochem Biophys; 2021 Mar; 700():108790. PubMed ID: 33549528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutations in the transcriptional regulator MeCP2 severely impact key cellular and molecular signatures of human astrocytes during maturation.
    Sun J; Osenberg S; Irwin A; Ma LH; Lee N; Xiang Y; Li F; Wan YW; Park IH; Maletic-Savatic M; Ballas N
    Cell Rep; 2023 Jan; 42(1):111942. PubMed ID: 36640327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ube3a expression is not altered in Mecp2 mutant mice.
    Jordan C; Francke U
    Hum Mol Genet; 2006 Jul; 15(14):2210-5. PubMed ID: 16754645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A role for glia in the progression of Rett's syndrome.
    Lioy DT; Garg SK; Monaghan CE; Raber J; Foust KD; Kaspar BK; Hirrlinger PG; Kirchhoff F; Bissonnette JM; Ballas N; Mandel G
    Nature; 2011 Jun; 475(7357):497-500. PubMed ID: 21716289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 4-hydroxynonenal protein adducts: Key mediator in Rett syndrome oxinflammation.
    Valacchi G; Pecorelli A; Cervellati C; Hayek J
    Free Radic Biol Med; 2017 Oct; 111():270-280. PubMed ID: 28063942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. P152R Mutation Within MeCP2 Can Cause Loss of DNA-Binding Selectivity.
    Franklin D
    Interdiscip Sci; 2019 Mar; 11(1):10-20. PubMed ID: 30673959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome.
    Kim KY; Hysolli E; Park IH
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14169-74. PubMed ID: 21807996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.